You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
A report in this issue of Science Translational Medicine reveals that amplification of the FGFR1 gene—which encodes fibroblast growth factor receptor 1—is a major oncogenic aberration in squamous cell lung cancer. This genetic variation may represent the first relatively high-frequency therapeutic target of smoking-associated lung cancer.
Footnotes
-
Citation: N. C. Turner, M. J. Seckl, A therapeutic target for smoking-associated lung cancer. Sci. Transl. Med. 2, 62ps56 (2010).
- Copyright © 2010, American Association for the Advancement of Science
